Nothing said here yet.
to join the conversation.
| Roth Adam L.Director | Buy | 7,500 | $35.9K | Thu, Oct 15 |
| Roth Adam L.Director | Buy | 2,500 | $11.9K | Thu, Oct 15 |
| Roth Adam L.Director | Buy | 5,000 | $22.6K | Wed, Oct 14 |
Shareholders of Byrna would probably like to forget the past six months even happened. The stock dropped 23.5% and now trades at $4.77. This may have investors wondering how to approach the situation.
Non-lethal weapons company Byrna (NASDAQ:BYRN) missed Wall Street’s revenue expectations in Q3 2026, with sales falling 45.7% year on year to $15.3 million. Its non-GAAP loss of $0.08 per share was 59.1% above analysts’ consensus estimates.
Revenue fell 46% but gross margins expanded 500 basis points amid operational shifts.
Moby summary of Byrna Technologies Inc.'s Q3 2026 earnings call
Byrna Technologies (NASDAQ:BYRN) reported lower fiscal third-quarter revenue and a net loss as e-commerce sales declined and dealer and chain-store reorders slowed following earlier inventory restocking.
Byrna Technologies (BYRN) delivered earnings and revenue surprises of +13.33% and -4.61%, respectively, for the quarter ended August 2026. Do the numbers hold clues to what lies ahead for the stock?
Non-lethal weapons company Byrna (NASDAQ:BYRN) missed Wall Street’s revenue expectations in Q3 2026, with sales falling 45.7% year on year to $15.3 million. Its GAAP loss of $0.13 per share was 17% above analysts’ consensus estimates.
Non-lethal weapons company Byrna (NASDAQ:BYRN) will be reporting earnings this Thursday before market hours. Here’s what you need to know.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at aerospace and defense stocks, starting with Byrna (NASDAQ:BYRN).